Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (11-20 of 307) with videos related to

Pageof 31
Sort By:
The Urologic Clinics of North America|July 2, 2021
Genetically Informed Prostate Cancer ScreeningRohith Arcot, Todd M Morgan, Thomas J Polascik
Current Cancer Drug Targets|March 12, 2009
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayTodd M Morgan, Theodore D Koreckij, Eva Corey
Urology|April 2, 2019
EDITORIAL COMMENTUdit Singhal, Todd M Morgan, Jeffrey J Tosoian
The New England Journal of Medicine|January 31, 2024
Federal Oversight of Laboratory-Developed Tests. ReplyUdit Singhal, Aaron S Kesselheim, Todd M Morgan
Journal of Surgical Education|November 10, 2009
The impact of residency match information disseminated by a third-party websiteAlexander Kutikov, Todd M Morgan, Matthew J Resnick
Prostate International|October 26, 2020
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative reviewJae-Seung Chung, Todd M Morgan, Sung Kyu Hong
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Detection and characterization of circulating and disseminated prostate cancer cellsTodd M Morgan, Paul H Lange, Robert L Vessella
Current Opinion in Oncology|February 12, 2011
Bladder cancerTodd M Morgan, Kirk A Keegan, Peter E Clark
European Urology|December 23, 2018
Optimizing Prostate Cancer Surveillance: Using Data-driven Models for Informed Decision-makingBrian T Denton, Sarah T Hawley, Todd M Morgan
Translational Andrology and Urology|August 25, 2021
Biomarkers for detection of clinically significant prostate cancer: contemporary clinical data and future directionsNicholas W Eyrich, Todd M Morgan, Jeffrey J Tosoian
Pageof 31

Showing results (11-20 of 307) with videos related to

Sort By:
Pageof 31
The Urologic Clinics of North America|July 2, 2021
Genetically Informed Prostate Cancer ScreeningRohith Arcot, Todd M Morgan, Thomas J Polascik
Current Cancer Drug Targets|March 12, 2009
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayTodd M Morgan, Theodore D Koreckij, Eva Corey
Urology|April 2, 2019
EDITORIAL COMMENTUdit Singhal, Todd M Morgan, Jeffrey J Tosoian
The New England Journal of Medicine|January 31, 2024
Federal Oversight of Laboratory-Developed Tests. ReplyUdit Singhal, Aaron S Kesselheim, Todd M Morgan
Journal of Surgical Education|November 10, 2009
The impact of residency match information disseminated by a third-party websiteAlexander Kutikov, Todd M Morgan, Matthew J Resnick
Prostate International|October 26, 2020
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative reviewJae-Seung Chung, Todd M Morgan, Sung Kyu Hong
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Detection and characterization of circulating and disseminated prostate cancer cellsTodd M Morgan, Paul H Lange, Robert L Vessella
Current Opinion in Oncology|February 12, 2011
Bladder cancerTodd M Morgan, Kirk A Keegan, Peter E Clark
European Urology|December 23, 2018
Optimizing Prostate Cancer Surveillance: Using Data-driven Models for Informed Decision-makingBrian T Denton, Sarah T Hawley, Todd M Morgan
Translational Andrology and Urology|August 25, 2021
Biomarkers for detection of clinically significant prostate cancer: contemporary clinical data and future directionsNicholas W Eyrich, Todd M Morgan, Jeffrey J Tosoian
Pageof 31